Apollo Prices Offering of Senior Notes

Apollo logo

NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (the “Issuer” and, together with its consolidated subsidiaries, “Apollo”) today announced that it has priced an offering (the “Offering”) of $500 million aggregate principal amount of its 5.150% Senior Notes due 2035 (the “notes”).

The notes will be fully and unconditionally guaranteed by certain subsidiaries of the Issuer that are obligors under the Issuer’s outstanding debt securities. The Offering is expected to close on August 12, 2025, subject to customary closing conditions.

The notes will bear interest at a rate of 5.150% per annum, payable semi-annually in arrears on February 12 and August 12 of each year, commencing on February 12, 2026.

The net proceeds from the Offering will be approximately $495.5 million, after deducting the underwriting discount but before Offering expenses. Apollo intends to use the proceeds from the Offering for general corporate purposes, including to repay, upon the consummation of the previously announced acquisition of Bridge Investment Group Holdings Inc., all issued and outstanding senior secured notes of Bridge Investment Group Holdings LLC (“Bridge LLC”) (collectively, the “Bridge Senior Notes”) and certain other indebtedness of Bridge LLC, and to pay related fees and expenses in connection with the Offering and the use of proceeds therefrom.

Citigroup Global Markets Inc., BofA Securities, Inc., Barclays Capital Inc. and Goldman Sachs & Co. LLC are acting as joint book-running managers. Apollo Global Securities, LLC, BMO Capital Markets Corp., BNP Paribas Securities Corp., HSBC Securities (USA) Inc., MUFG Securities Americas Inc., Drexel Hamilton, LLC and Siebert Williams Shank & Co., LLC are acting as co-managers for the Offering.

The Offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission (the “SEC”). The Offering is being made by means of a prospectus and related preliminary prospectus supplement only. An electronic copy of the preliminary prospectus supplement, together with the accompanying prospectus, is available on the SEC’s website at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus may be obtained by contacting the joint book-running managers: Citigroup Global Markets Inc., telephone: 1-800-831-9146; BofA Securities, Inc., telephone: 1-800-294-1322; Barclays Capital Inc., telephone: 1-888-603-5847 and Goldman Sachs & Co. LLC, telephone: 1-866-471-2526.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This press release shall not constitute a notice of redemption with respect to the Bridge Senior Notes.

Forward-Looking Statements

In this press release, references to “Apollo,” “we,” “us,” “our” and the “Company” refer collectively to Apollo Global Management, Inc. and its subsidiaries, or as the context may otherwise require. This press release may contain forward-looking statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, discussions related to Apollo’s expectations regarding the completion of, and the use of proceeds from, the sale of the notes, the performance of its business, its liquidity and capital resources and the other non-historical statements in the discussion and analysis. These forward-looking statements are based on management’s beliefs, as well as assumptions made by, and information currently available to, management. When used in this press release, the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “target” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and variations of such words or similar expressions are intended to identify forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. These statements are subject to certain risks, uncertainties and assumptions, including risks relating to inflation, interest rate fluctuations and market conditions generally, international trade barriers, domestic or international political developments and other geopolitical events, including geopolitical tensions and hostilities, the impact of energy market dislocation, our ability to manage our growth, our ability to operate in highly competitive environments, the performance of the funds we manage, our ability to raise new funds, the variability of our revenues, earnings and cash flow, the accuracy of management’s assumptions and estimates, our dependence on certain key personnel, our use of leverage to finance our businesses and investments by the funds we manage, the ability of Athene Holding Ltd. (“Athene”) to maintain or improve financial strength ratings, the impact of Athene’s reinsurers failing to meet their assumed obligations, Athene’s ability to manage its business in a highly regulated industry, changes in our regulatory environment and tax status, and litigation risks, among others. We believe these factors include but are not limited to those described under the section entitled “Risk Factors” in the Issuer’s annual report on Form 10-K filed with the SEC on February 24, 2025, as such factors may be updated from time to time in the Issuer’s periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the Issuer’s other filings with the SEC. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law. This press release does not constitute an offer of Apollo or any Apollo fund.

Contacts

For investors please contact:
Noah Gunn
Global Head of Investor Relations
Apollo Global Management, Inc.
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
Apollo Global Management, Inc.
(212) 822-0491
communications@apollo.com

Categories: News

AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities with Acquisition of ImmunoPrecise Antibodies Europe from ImmunoPrecise Antibodies Ltd.

WASHINGTON, D.C. and NORWICH, CT – August 6, 2025 – Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company AVS Bio, a leading global provider of critical inputs and services for the bioprocessing and biologics industries, acquired ImmunoPrecise Antibodies (Europe) B.V. (“IPA Europe” or the “Company”).  IPA Europe is a carve-out of ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a biotherapeutics company leveraging proprietary technologies, including its LENSai™ platform, to accelerate the discovery of next-generation biologics. The acquisition expands AVS Bio’s European footprint and adds advanced capabilities in antibody discovery, protein expression, and organoid growth factor development and manufacturing to its growing service portfolio.

With facilities in both Utrecht and Oss in the Netherlands, IPA Europe offers a comprehensive suite of antibody discovery, engineering, and characterization services. In addition to its industry-leading hybridoma and B-cell screening platforms, the Company has deep expertise in recombinant protein expression and offers scalable protein production for both research and pre-clinical applications. These capabilities enable IPA Europe to serve as a true end-to-end partner for biotechnology and pharmaceutical companies developing next-generation biologics including antibody-based therapeutics, novel diagnostics, and vaccines. Following the acquisition, IPA Europe will continue to operate under its existing management as a strategic European hub within AVS Bio’s brand and network which serves large-scale pharmaceutical customers globally across both human and animal health markets.

Jac Price, CEO of AVS Bio, said, “IPA Europe brings exceptional technical capabilities and a reputation for scientific rigor that aligns perfectly with our mission to support customers from early discovery through commercial manufacturing. This acquisition significantly enhances our service offering and geographic reach, and we’re excited to welcome the IPA Europe team into the AVS Bio family.”

“This acquisition reflects AVS Bio’s strategic commitment to grow through both organic investment and targeted M&A,” added Malcolm Little, a Partner at Arlington Capital Partners. “IPA Europe is a natural fit, offering complementary capabilities in antibody discovery and recombinant protein manufacturing that will accelerate AVS Bio’s expansion into the upstream biologics R&D value chain. This transaction marks a key milestone in AVS Bio’s broader strategy to build a diversified biologics services platform serving the therapeutic innovation markets.”

Ilse Roodink and Roland Romijn, General Managers of IPA Europe, together commented, “We’re thrilled to join forces with AVS Bio. Their platform offers immediate opportunities for us to scale our operations, invest in next-generation technologies, and better serve our clients with an end-to-end continuum of biologics development capabilities.”

Arlington has an extensive track record of building leading companies in highly regulated industries that are critical to healthcare infrastructure, government systems and national security. Within healthcare, Arlington focuses on working with businesses that save lives, improve the delivery of products and services and reduce costs for patients and providers. Other notable recent healthcare sector investments the firm has made include Afton ScientificEverest Clinical ResearchGrand River Aseptic ManufacturingMillstone Medical OutsourcingRiverpoint Medical, and TEAM Technologies.

Edgemont Partners served as exclusive sell-side advisor to ImmunoPrecise Antibodies Ltd. in connection with the transaction.

About Arlington Capital Partners
Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the healthcare, government services and technology, and aerospace and defense sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington’s website at www.arlingtoncap.com and follow Arlington on LinkedIn.

About AVS Bio
Headquartered in Norwich, CT, AVS Bio is a global provider of specific pathogen free (“SPF”) laboratory products and services that support the development and manufacture of vaccines, therapeutics, and biologics. The Company supplies leading manufacturers with critical bioprocessing inputs including SPF eggs, antigens, and antibodies, and also offers diagnostic testing and GMP support services. AVS Bio operates over 20 facilities across North America and Europe and is a portfolio company of Arlington Capital Partners. For more information, visit AVS Bio’s website at www.avsbio.com.

About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is advancing Bio-Native™ AI at the intersection of biology and computation. The Company’s LENSai™ and HYFT® platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering next-generation workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology.

About IPA Europe
IPA Europe, based in Utecht and Oss, the Netherlands, provides comprehensive services in antibody discovery, engineering, and functional characterization as well as recombinant protein and organoid growth factor development and production. With a focus on innovation and quality, IPA Europe supports leading biotech and pharmaceutical companies across the globe in the development of next-generation biologics.

Media Contact

Ryan FitzGibbon

Pro-arlington@prosek.com

Categories: News

Tags:

Elysian Capital III LP supports Activate Group Holdings Limited to acquire Avant Group

Elysian Capital

Elysian Capital is pleased to announce further investment in Fund III portfolio company, Activate Group Holdings Limited (“Activate”) to support the acquisition of Avant Consult Ltd (“Avant Group”).

Activate provides accident management services to insurance groups and corporate fleet operators through its MRN and Sopp+Sopp brands, undertaking the vehicle repairs either in house through its own network of repair centres or externally through its network of third-party repair centres. Elysian Capital is supporting management in their expansion of the Group through both organic and acquisitive growth.

Avant is a well-established collision repair specialist known for its manufacturer programme expertise, bodyshop management technology, and award-winning repair network. As part of the deal Activate Group has acquired Avant Group’s three key brands: Avant Consult, Avant Repair Network and Bodynet.

The move brings together two highly complementary businesses with shared strengths in the insurance, fleet and repair sectors – with a combined track record of managing hundreds of thousands of motor claims each year.

Avant’s leadership team will remain in place. Mark Johnstone will continue to head up the business, joining the Activate Group Executive Team as Managing Director of AvantGroup.

Hannah Wilcox, Activate Group CEO said:

“This marks a significant milestone for Activate Group. Avant Group’s particular expertise enhances our existing proposition and supports our ambition to deliver the UK’s most advanced, end-to-end accident and repair solutions. Together, we’re giving insurers, fleets and partners even more reasons to choose our services.”

Mark Johnstone added:

“Joining Activate Group is the next natural step in our growth. We’re proud of the service and culture we’ve built, and the strong relationships we have with our clients and repair partners. Becoming part of Activate Group gives us the opportunity to grow faster, expand our reach and bring even more value to our clients, partners and people, and we’re excited about what we can now achieve together.”

Elysian Capital and Activate were advised by: Squire Patton Boggs (legal); Eight Advisory (financial and tax); and Aon (Insurance). The shareholders of Avant were advised by Brown Butler (corporate finance); and Weightmans (legal).

Contact

Elysian Capital LLP

Manfield House

1 Southampton Street

London

WC2R 0LR

T: +44 (0) 207 925 80 50

Categories: News

Tags:

Servier and BC Partners enter exclusive negotiations for the sale of Biogaran

BC Partners Logo
  • BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication.
  • Leveraging its deep pharmaceutical sector expertise, operational insight, and long-term capital, BC Partners aims to help accelerate growth while continuing to champion essential, affordable healthcare in France.
  • With nearly four decades of investment experience in France, BC Partners is a trusted partner to local entrepreneurs, founders, and management teams.

Servier, an international pharmaceutical company governed by a foundation, and BC Partners, a leading European investment firm, have today announced that they have entered into exclusive negotiations regarding BC Partners’ acquisition of Biogaran, one of France’s largest generic drug companies. The terms of the transaction were not disclosed.

Biogaran, a leader in the generic market in France and an active contributor to cost savings in the French healthcare system, was founded by Servier over 25 years ago. Over the years, the company has established itself as a key player in the pharmaceutical industry. Today, Biogaran offers treatments across the full spectrum of therapeutic areas — from everyday conditions to the most serious diseases — and supplies a wide range of medicines, including antibiotics, antidiabetics, and anticancer drugs.

In partnership with management, BC Partners will continue to build on the company’s position as a critical provider of generic pharmaceuticals to the French market, whilst helping to fuel further expansion in biosimilars and consumer healthcare products, which have been identified as major new cost-saving drivers for the French healthcare system.

BC Partners, founded in Europe, brings extensive experience in the French market, having invested more than €4 billion across France and the Benelux region since opening its Paris office in 1987. BC Partners combines this local presence with a strong track record of partnering with healthcare leaders and innovators, including investments in companies such as Pharmathen, Synthon, and France-based Havea, making it a natural partner of choice for Biogaran.

Cédric Dubourdieu, Partner and Head of France at BC Partners, added: “Biogaran is a recognised leader in the French healthcare sector, with a rich history and a compelling opportunity for continued growth. We look forward to helping drive the business forwards, in partnership with management, while respecting the vital role Biogaran plays within France’s healthcare landscape, and French society more broadly.”

Mark Hersee, Partner and Co-head of Healthcare at BC Partners, commented: “Biogaran is a pioneer in generic drugs, a market we know incredibly well, and one where we have developed tried-and-tested playbooks for growth over many years. Our experience in this space, from successful investments in generic pharmaceutical leaders such as Pharmathen and Synthon, means we are well positioned to help the company identify opportunities and boost its full potential.”

We see this potential sale as a fantastic opportunity for Biogaran’s future. It is fully in line with Biogaran’s vision and strategy to consolidate our position as the leader in generic drugs in France, while expanding into new high-potential market segments. This would enable us to continue to fully embody our mission of contributing to the sustainability of the French healthcare system for the benefit of patients and healthcare professionals by ensuring better access to care. We look forward to working with BC Partners.” said Guillaume Recorbet, CEO of Biogaran.

“This project would be perfectly in line with the strategic orientations of Biogaran and Servier. On the one hand, this project would entail new ownership for Biogaran that would boost its development potential. BC Partners is a leading European investor and would be perfectly positioned to lead the next stage of development for Biogaran, in line with the interests of its stakeholders, which is a strategic condition for Servier. On the other hand, the proceeds from this transaction should enable Servier to accelerate its focus, particularly on innovative treatments in oncology and neurology, and to continue creating value in France, as we have been committed to doing for more than 70 years.” said Olivier Laureau, president of Servier.

Servier was advised by Lazard and Dentons for this project. BC Partners was advised by Rothschild & Cie, Kirkland & Ellis, Gide Loyrette Nouel and Eight Advisory.

The proposed transaction remains subject to the finalisation of definitive agreements, the appropriate employee representative processes, and the usual regulatory approvals.

Categories: News

Tags:

DentalXChange Announces Recapitalization with KKR to Advance Technology and Innovation in Dental Revenue Cycle Management

KKR

KKR’s strategic investment to accelerate DentalXChange’s product development and scalable growth to drive value creation across the industry

IRVINE, Calif.–(BUSINESS WIRE)– KKR, a leading global investment firm, today announced the recapitalization of DentalXChange (“DXC” or the “Company”), a leading provider of revenue cycle management (RCM) solutions for the U.S. dental market. In connection with the transaction, Bregal Sagemount exited its investment in DXC, following a successful strategic partnership with the Company.

As a critical technology partner for the dental ecosystem for over three decades, DXC facilitates more than two billion transactions annually and helps industry stakeholders navigate the complexities of dental RCM. The Company’s comprehensive product suite combined with strong collaboration with payers, providers, and practice management system partners has enabled DXC to deliver significant efficiencies in the ecosystem, which are poised to accelerate over the coming years.

“We seek opportunities where we can serve as differentiated partners with management teams to build world-class businesses that can positively impact the healthcare system. We have long admired the important role that DXC plays in the dental value chain, with its robust network and best-in-class solution set,” said Hunter Craig, Managing Director at KKR. “Customers consistently view DXC as a collaborative and innovative business partner, and we look forward to helping the Company further expand its capabilities and streamline operations for all stakeholders,” added Alex Ward, Director at KKR.

“KKR’s deep expertise across the dental landscape, experience with technology-led innovation and extensive network of key industry partners will meaningfully accelerate DXC’s next phase of growth,” said DentalXChange CEO, Paul Kaiser. “We look forward to expanding our use of automation and AI to reduce administrative complexity, enhance provider workflows, and create a seamless payer experience.”

“It has been a privilege to partner with the DXC team and support the Company’s growth through key investments in technology and talent,” said Bregal Sagemount Partner, Blair Greenberg. “We are proud of what we accomplished together and wish the team continued success in this next phase of growth,” added Phil Yates, Partner at Bregal Sagemount.

DentalXChange will continue to operate under its current leadership team, led by CEO Paul Kaiser.

As part of the recapitalization, KKR will support DXC to create a broad-based equity ownership program, which will provide equity to all employees at the Company, enabling the full DXC team to participate in growth and value creation. This broad-based equity strategy is based on the belief that team member engagement through ownership is a key driver in building stronger companies. Since 2011, 70 KKR portfolio companies have awarded billions of dollars of total equity value to nearly 170,000 non-senior management employees.

KKR is making its investment in DentalXChange through its Ascendant Fund, which invests in middle market businesses in North America as part of KKR’s Americas Private Equity platform.

TripleTree served as financial advisor to DentalXChange and Goodwin Procter LLP provided legal counsel to Bregal Sagemount. William Blair served as exclusive financial advisor and Kirkland & Ellis LLP served as legal advisor to KKR.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

About DentalXChange

Since 1989, DentalXChange has been on the forefront of modernizing and innovating dental claims creating dental RCM solutions that bring ease to the payments process. Today, it has grown to support a current base approaching 200,000 dental providers and connectivity to nearly 1,400 payer plans. Headquartered in Irvine, CA, through its own clearinghouse, state of art technology consisting of modern APIs, and secure Web portals, DentalXChange processes over 1B EDI transactions, consisting of more than 300MM dental claims annually.

About Bregal Sagemount

Bregal Sagemount is a leading growth-focused private capital firm with more than $7.5 billion of cumulative capital raised. The firm provides flexible capital and strategic assistance to market-leading companies in high-growth sectors across a wide variety of transaction situations. Bregal Sagemount has invested in over 70 companies in a variety of sectors, including software, information / data services, financial technology & financial services, digital infrastructure, healthcare IT, and business & consumer services. The firm has offices in New York, Palo Alto, and Dallas. For more information, visit the Sagemount website: www.sagemount.com (http://www.sagemount.com/) or follow us on LinkedIn. (https://www.linkedin.com/company/bregal-sagemount)

Media:
KKR
Brooke Rustad
Brooke.rustad@kkr.com

DentalXChange
Marci Sweet
msweet@dentalxchange.com

Source: KKR & Co. Inc.

 

Download PDF

Categories: News

Tags:

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

Blackstone
  • Strengthens MannKind’s capital structure with flexible, long-term, non-dilutive funding
  • MannKind to receive $75 million in cash at closing

DANBURY, Conn., WESTLAKE VILLAGE, Calif. and NEW YORK – August 06, 2025 – MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, and funds managed by Blackstone (“Blackstone”) today announced that they have entered into an up to $500 million strategic financing agreement. The financing agreement provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.

“This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.”

“MannKind has a strong commercial track record, diversified product portfolio, and exceptional management team,” said Jonathan Brayman, Managing Director at Blackstone Credit & Insurance. “This strategic financing provides flexible capital to support MannKind’s growth initiatives while positioning Blackstone as a long-term partner to the company. We believe access to our value creation platform and deep bench of life sciences expertise will support MannKind’s commercialization efforts, as well as its organic and inorganic pipeline.”

The up to $500 million senior secured credit facility consists of a $75 million initial term loan funded at closing, a $125 million delayed draw term loan (DDTL) available for the next 24 months, subject to customary drawdown conditions, and an additional $300 million uncommitted DDTL available at the mutual consent of MannKind and Blackstone. The facility bears interest at a calculated SOFR variable rate plus 4.75% (which may be increased by 25 basis points if a total leverage ratio is exceeded). The facility matures in August 2030 and does not provide for scheduled amortization payments during the term.

About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.

We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication.

With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.

Please visit mannkindcorp.com to learn more, and follow us on LinkedInFacebookX or Instagram.

About Blackstone
Blackstone is the world’s largest alternative asset manager. Blackstone seeks to deliver compelling returns for institutional and individual investors by strengthening the companies in which the firm invests. Blackstone’s $1.2 trillion in assets under management include global investment strategies focused on real estate, private equity, credit, infrastructure, life sciences, growth equity, secondaries and hedge funds. Further information is available at https://www.blackstone.com/. Follow @blackstone on LinkedIn, X (Twitter), and Instagram.

Forward-Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, statements about: financing plans, cash position, business development initiatives, commercial team expansion, the potential launch of the pediatric indication for Afrezza, if approved, the expected benefits of the senior secured credit facility, the ability of MannKind to drawdown the $125 million DDTL, and the availability of the $300 million additional DDTL. These statements involve risks and uncertainties. Words such as “believes”, “anticipates”, “plans”, “expects”, “intends”, “will”, “goal”, “potential” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon MannKind’s current expectations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, the risk that the DDTLs may not be available to MannKind due to failure to meet required drawdown conditions or the inability to obtain consent from Blackstone, the risk that issues that develop in the preparation of data releases and filings may subject us to unanticipated delays, risks associated with the regulatory review process as well as other risks detailed in MannKind’s filings with the Securities and Exchange Commission (SEC), including under the “Risk Factors” heading of its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the SEC on August 6, 2025. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and MannKind undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

AFREZZA and MANNKIND are registered trademarks of MannKind Corporation.

For MannKind:
Investor Relations
Ana Kapor
(818) 661-5000
ir@mnkd.com

Media Relations
Christie Iacangelo
(818) 292-3500
media@mnkd.com

For Blackstone:
Thomas Clements
(646) 482-6088
Thomas.Clements@blackstone.com

Categories: News

Tags:

Blackstone Announces a Tender Offer for Japan’s Leading IT Services Provider, TechnoPro, its Largest Investment Ever in Japan

Blackstone

Marks the firm’s 24th private equity transaction in Asia since 2024, continuing its work to identify great companies, build businesses, and deliver for investors
 
TOKYO – August 6, 2025 – Blackstone (NYSE:BX) announced today that private equity funds and vehicles managed by Blackstone (“Blackstone”) have announced its intention to make a tender offer for all of the interests in TechnoPro, Japan’s leading IT services provider. This offer, valued at nearly $3.5 billion (~JPY 507 billion), will be the firm’s largest investment to date in Japan across strategies.

TechnoPro is Japan’s leading IT services provider, delivering mission-critical solutions in IT development and product R&D across hardware and software primarily to Japan’s large corporations. It has more than 28,000 engineers and researchers and 2,500 clients in industries such as automotive, IT services, and semiconductor.

Atsuhiko Sakamoto, Head of Private Equity Japan, Blackstone, said: “This is a compelling opportunity that aligns with our strategy of investing in Japan’s future. We are investing in a high-quality IT services provider, which is bolstered by secular tailwinds in the digitization of the economy and artificial intelligence. TechnoPro attracts some of the best talent in the industry and provides mission-critical services that empower Japan’s blue-chip companies. We are excited to bring the full breadth of Blackstone’s scale, resources, and expertise in IT services and AI to help accelerate the company’s growth and its continued success.”

Takeshi Yagi, President, Representative Director and CEO at TechnoPro, said: “Over the past 30 years, TechnoPro has achieved steady growth by leveraging its strengths in sales capabilities, technical expertise, recruitment power, and talent development. As a result, the company has earned the trust of its clients and established itself as a leading player in Japan’s IT services. By collaborating with Blackstone – which boasts a strong track record in AI and digitalization and deep insights into global technology trends – we are confident that TechnoPro is poised to reach even greater heights of success.”

This is Blackstone’s seventh Private Equity investment in Japan, representing significant momentum for the firm and its commitment to the country. This will be the third deal this year for Blackstone Japan’s Private Equity business following the closing of I’rom Group Co., Ltd. and CIMIC Co., Ltd. and its third deal in Japan’s technology sector following the 2024 closings of Sony Payment Services Inc. and Infocom Corporation.

Blackstone has made substantial investments in the Asia Pacific region over the last 20 years and been a builder of businesses. Since 2024, it has executed 24 Private Equity investments and sales across the region, driving transformation for the companies it invests in and working to deliver value for investors.

Blackstone expects to commence the tender offer on August 7, 2025. Please refer to the announcement issued today, titled “Notice Concerning Commencement of Tender Offer for Shares, Etc. of TechnoPro Holdings, Inc. (Code: 6028) by BXJE II Holding KK” for details regarding the terms and conditions of the tender offer.

This press release has been prepared for the purpose of informing the public of the tender offer and has not been prepared for the purpose of soliciting an offer to sell, or making an offer to purchase, any securities. If shareholders wish to make an offer to sell their shares in the tender offer, they should first read the tender offer explanation statement for the tender offer and offer their shares for sale at their own discretion. This press release shall neither be, nor constitute a part of, an offer to sell or purchase, or a solicitation of an offer to sell or purchase, any securities, and neither this press release (or a part thereof) nor its distribution shall be interpreted to be the basis of any agreement in relation to the tender offer, and this press release may not be relied on at the time of entering into any such agreement.

The tender offer will be conducted in accordance with the procedures and information disclosure standards prescribed by the Financial Instruments and Exchange Act of Japan, which may differ from the procedures and information disclosure standards in the United States. In particular, Section 13(e) and Section 14(d) of the U.S. Securities Exchange Act of 1934, as amended, do not and the rules prescribed thereunder do not or may not apply to the tender offer, and the tender offer is not intended to fully conform to those procedures and standards.

The financial advisors to Blackstone and TechnoPro, as well as the tender offer agent (including their respective affiliates) may, in their ordinary course of business, engage in purchases of the shares of TechnoPro for their own account or for their customers’ accounts to the extent permitted under the Financial Instruments and Exchange Act of Japan, and in accordance with Rule 14e-5(b) of the U.S. Securities Exchange Act of 1934, as amended, and other applicable laws and regulations, during the period prior to the commencement of the tender offer or during the tender offer. Such purchases may be conducted at a market price through a market transaction, or at a price determined through negotiations off-market. In the event that information regarding such purchases is disclosed in Japan, such information will also be disclosed on the English website of the applicable person conducting such purchases, or will otherwise be made publicly available.

Unless otherwise specified, all procedures relating to the tender offer are to be conducted entirely in Japanese. If all or a part of the documentation relating to the tender offer is prepared in the English language and there is any inconsistency between the English-language documentation and the Japanese-language documentation, the Japanese-language documentation will prevail.
 
About Blackstone
Blackstone is the world’s largest alternative asset manager. Blackstone seeks to deliver compelling returns for institutional and individual investors by strengthening the companies in which the firm invests. Blackstone’s $1.2 trillion in assets under management include global investment strategies focused on real estate, private equity, credit, infrastructure, life sciences, growth equity, secondaries and hedge funds. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, X (Twitter), and Instagram.

Media Contact
Mariko Sanchanta
Mariko.Sanchanta@Blackstone.com
080-8702-7386

Kekst CNC
Blackstone@Kekstcnc.com
090-3239-9348

Categories: News

Tags:

Apollo Funds to Acquire Majority Stake in Stream Data Centers, Forming a Scaled Digital Infrastructure Leader

Apollo logo

Apollo’s Long-Term Capital to Accelerate Stream’s 4+ GW Development Pipeline and Enable Deployment of Billions Into Critical U.S. Infrastructure

NEW YORK and DALLAS, Aug. 06, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have agreed to acquire a majority interest in Stream Data Centers (“SDC” or the “Company”) from Stream Realty Partners (“SRP”). With Apollo’s backing, SDC is positioned to execute on a multi-gigawatt pipeline while enabling Apollo Funds and affiliates to potentially deploy billions of dollars into next-generation digital infrastructure. SDC’s management team will retain a minority stake and continue leading the business.

SDC builds, leases, manages and operates hyperscale data center campuses and has delivered more than 20 campuses to date. The Company controls over 4 gigawatts of long-term powered land and has a robust near-term pipeline. With Apollo Funds’ capital and strategic support, SDC plans to scale platform-wide development to meet accelerating demand from hyperscale cloud and AI providers across key Tier 1 and Tier 2 U.S. markets.

“Stream Data Centers represents a landmark digital infrastructure transaction for Apollo,” Apollo Partners Joseph Jackson and Trevor Mills said. “With deep development expertise and a valuable long-term land fund in key growth markets, we believe SDC is uniquely positioned to serve the infrastructure needs of the world’s most sophisticated technology customers. Apollo will bring scaled capital and structuring capabilities to help drive recurring origination across our ecosystem. We look forward to partnering with SDC as a key operating platform to deliver next-gen capacity at scale.”

Michael Lahoud and Paul Moser, Co-Managing Partners of Stream Data Centers, stated, “We are excited to partner with Apollo on the next phase of SDC’s growth amid robust demand for data center solutions. After more than two decades of delivering exceptional data center experiences, SDC has created a building and operating model with very strong fundamentals based on collaborative, enduring customer relationships. This symbiotic relationship with Apollo amplifies that existing strength, offering access to the capital required to significantly scale our developments at the rate hyperscale customers demand. We look forward to working with the Apollo team to execute on our pipeline — and we extend our sincere gratitude to SRP for providing the firm foundations that have helped SDC become the organization it is today.”

Apollo estimates that data centers will require several trillion dollars of global investment over the next decade, driven by a secular global industrial renaissance, with substantial investments required in power, facilities and semiconductor chips. Since 2022, Apollo-managed funds have deployed approximately $38 billion into next-generation infrastructure investments, including renewable energy, digital platforms and compute capacity. The firm plans to significantly scale its investment in these areas in the coming years, both through Stream and as a capital partner to other market participants.

As part of the transaction, Apollo Funds and SRP will commit new capital to Stream’s existing data center land fund to accelerate site development for 650 MW of near-term power capacity across campuses in metro Chicago, Atlanta and Dallas. A newly formed subsidiary of the Apollo Funds will assume the role of investment manager of the land fund.

The transaction is subject to customary closing conditions and is expected to be completed in 2025.

Goldman Sachs & Co. acted as sole financial advisor to Stream Data Centers, while Akin Gump Strauss Hauer & Feld LLP served as legal counsel. Moelis & Company acted as financial advisor to the Apollo Funds on the transaction, while Latham & Watkins LLP served as legal counsel.

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of June 30, 2025, Apollo had approximately $840 billion of assets under management. To learn more, please visit www.apollo.com.

About Stream Data Centers
Since 1999, Stream Data Centers has set new standards for innovation, operational excellence and sustainability in the data center industry. With over 90% of its inventory leased to Fortune 100 customers, the company has acquired, developed and managed complex data center projects for the world’s most demanding users.

From location strategy and site selection to data center construction and operations, Stream develops wholesale colocation capacity and build-to-suit facilities for hyperscale and enterprise users in major markets across the United States. As the company’s site development affiliate, Headwaters employs a team of hyperscale experts dedicated to building a land bank for the data center industry, helping Stream Data Centers and others uncover low-risk land sites for optimum data center development. Additionally, Stream Data Centers provides energy procurement services with a focus on reducing market risk and providing low-cost renewable energy options. To learn more, please visit www.streamdatacenters.com.
Stream Data Centers is headquartered in Dallas, Texas.

About Stream Realty Partners
Stream Realty Partners is a national commercial real estate firm offering an integrated platform of leasing, investment and development services. This includes tenant and landlord representation, Legendary CX property management, capital markets, investment management and sales, construction, construction management, national program management, workplace strategies, strategic marketing, and dedicated research. The company is headquartered in Dallas with operations in core markets coast to coast. Since 1996, Stream has grown to more than 1700 professionals and now completes annual transactions valued at more than $10 billion in office, industrial, retail, healthcare, land, and data center properties. For information, visit www.streamrealty.com and follow Stream on LinkedInInstagramX, and Facebook.

Contacts
For Apollo:

Noah Gunn
Global Head of Investor Relations
Apollo Global Management, Inc.
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
Apollo Global Management, Inc.
(212) 822-0491
Communications@apollo.com

For Stream Data Centers:

Mary Morgan
Vice President of Marketing & Communications
info@stream-dc.com

For Stream Realty Partners:
Molly McMurtry
Stream Realty Partners
press@streamrealty.com

Categories: News

Tags:

Blackstone Announces Agreement to Acquire Enverus

Hellman & Friedman

Blackstone (NYSE: BX) announced today that private equity funds affiliated with Blackstone (“Blackstone”) have entered into a definitive agreement to acquire Enverus, a premier data analytics energy intelligence platform, from Hellman & Friedman and Genstar Capital.

Enverus was founded in 1999 and is a comprehensive data analytics platform empowering its customers’ capital allocation and asset optimization decisions across the entire energy ecosystem. Today, it is the largest and fastest-growing SaaS company and analytics provider dedicated to the energy market. It enables its 8,000 customers across 50 countries with real-time access to analytics, insights, and benchmark data from generative AI and partnerships with more than 95 percent of U.S. energy producers and 40,000 suppliers.

“This is more than a transaction – it’s a launchpad,” said Manuj Nikhanj, CEO of Enverus. “Blackstone shares our conviction that the future of energy will be defined by AI, real-time intelligence, and bold execution. Their global reach and deep expertise across energy, infrastructure, and data-rich industries will accelerate our momentum – helping us scale faster, build smarter, and deliver transformational outcomes for our customers. It is thanks to a strong partnership with H&F that Enverus is the company we are today. I am incredibly proud of what our team has built – especially our breakthrough work in power markets – and more excited than ever for what comes next.”

Eli Nagler and Bilal Khan, Senior Managing Directors at Blackstone, said: “As the leading energy-dedicated SaaS platform, Enverus’ advanced analytics and technology solutions are critical for its customers as they navigate unprecedented AI-driven electricity demand growth and the broader energy transition. We believe Blackstone’s energy market expertise and network can further enhance the company’s growth trajectory, and look forward to partnering with Manuj and the Enverus team.”

“After four years of tremendous partnership, Enverus stands as the clear SaaS, data, and analytics leader empowering the energy market,” said Ben Farkas, Partner at Hellman & Friedman. “We set out with a mission to build on the company’s core strengths, accelerate innovation, and expand its reach across the energy value chain. Today they are pioneering GenAI-powered solutions, scaling into new markets, and enabling smarter and more efficient decisions for customers worldwide. The company’s growth and culture of innovation have set a new standard for the industry. It’s been a privilege to partner with Manuj Nikhanj, Jeff Hughes, and the full Enverus team. We are confident Enverus is exceptionally well-positioned to shape the future of global energy.”

“Supporting Enverus through this exciting period of innovation and growth has been a great journey,” said Eli Weiss, Managing Partner of Genstar Capital. “We’re proud of the team’s achievements and are confident they are well positioned for continued success.”

Enverus represents the latest in a number of recent transactions Blackstone has announced behind its high-conviction investment themes in electricity demand growth and the ongoing energy transition, such as TXNM Energy, Potomac Energy Center, Sediver, Westwood Professional Services, Trystar, and others. Blackstone’s core private equity strategy, Blackstone Energy Transition Partners, and Blackstone’s private equity strategy for individual investors are each expected to invest in Enverus as part of this transaction.

Terms of the transaction were not disclosed. The transaction is expected to close by the end of the year, subject to customary conditions. Citi and Morgan Stanley & Co. LLC acted as financial advisors and Kirkland & Ellis LLP acted as legal advisor to Enverus and Hellman & Friedman. RBC Capital Markets served as financial advisor and Simpson Thacher & Bartlett LLP served as legal advisor to Blackstone.

About Blackstone
Blackstone is the world’s largest alternative asset manager. Blackstone seeks to deliver compelling returns for institutional and individual investors by strengthening the companies in which the firm invests. Blackstone’s $1.2 trillion in assets under management include global investment strategies focused on real estate, private equity, credit, infrastructure, life sciences, growth equity, secondaries and hedge funds. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, X (Twitter), and Instagram.

About Enverus
Enverus is the energy industry’s most trusted source for decision intelligence. With petabytes of proprietary data, deep domain expertise, and AI-native technology, Enverus empowers customers to invest smarter, operate more efficiently, and scale faster — across upstream, midstream, minerals, power, and renewables — all while navigating the most complex energy market in history. Learn more at www.enverus.com.

About Hellman & Friedman
Hellman & Friedman is a preeminent global private equity firm with a distinctive investment approach focused on a limited number of large-scale equity investments in high-quality growth businesses. H&F seeks to partner with world-class management teams where its deep sector expertise, long-term orientation, and collaborative partnership approach enable companies to flourish. H&F targets outstanding businesses in select sectors, including technology, financial services, healthcare, consumer services & retail, and information, content & business services. Since its founding in 1984, H&F has invested in over 100 companies and has over $115 billion in assets under management as of December 31, 2024. Learn more about H&F’s defining investment philosophy and approach to sustainable outcomes at www.hf.com.

About Genstar Capital
Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high-quality companies for over 35 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $50 billion of assets under management and targets investments focused on targeted segments of the financial services, software, healthcare, and industrials industries.

MEDIA CONTACTS: 

Blackstone
Matt Anderson
Matthew.Anderson@Blackstone.com
(518) 248-7310

Jennifer Heath
Jennifer.Heath@Blackstone.com
(347) 603-9256

Enverus
Jon Haubert
Jon.Haubert@enverus.com
(303) 396-5996

Hellman & Friedman
Dan Abernethy
Dan.Abernethy@fgsglobal.com
(646) 238-3902

Categories: News

Tags:

Blackstone Announces Agreement to Acquire Enverus

NEW YORK, NY, AUGUST 6, 2025—Blackstone (NYSE: BX) announced today that private equity funds affiliated with Blackstone (“Blackstone”) have entered into a definitive agreement to acquire Enverus, a premier data analytics energy intelligence platform, from Hellman & Friedman and Genstar Capital.

Enverus was founded in 1999 and is a comprehensive data analytics platform empowering its customers’ capital allocation and asset optimization decisions across the entire energy ecosystem. Today, it is the largest and fastest-growing SaaS company and analytics provider dedicated to the energy market. It enables its 8,000 customers across 50 countries with real-time access to analytics, insights, and benchmark data from generative AI and partnerships with more than 95 percent of U.S. energy producers and 40,000 suppliers.

“This is more than a transaction – it’s a launchpad,” said Manuj Nikhanj, CEO of Enverus. “Blackstone shares our conviction that the future of energy will be defined by AI, real-time intelligence, and bold execution. Their global reach and deep expertise across energy, infrastructure, and data-rich industries will accelerate our momentum – helping us scale faster, build smarter, and deliver transformational outcomes for our customers. It is thanks to a strong partnership with H&F that Enverus is the company we are today. I am incredibly proud of what our team has built – especially our breakthrough work in power markets – and more excited than ever for what comes next.”

Eli Nagler and Bilal Khan, Senior Managing Directors at Blackstone, said: “As the leading energy-dedicated SaaS platform, Enverus’ advanced analytics and technology solutions are critical for its customers as they navigate unprecedented AI-driven electricity demand growth and the broader energy transition. We believe Blackstone’s energy market expertise and network can further enhance the company’s growth trajectory, and look forward to partnering with Manuj and the Enverus team.”

“After four years of tremendous partnership, Enverus stands as the clear SaaS, data, and analytics leader empowering the energy market,” said Ben Farkas, Partner at Hellman & Friedman. “We set out with a mission to build on the company’s core strengths, accelerate innovation, and expand its reach across the energy value chain. Today they are pioneering GenAI-powered solutions, scaling into new markets, and enabling smarter and more efficient decisions for customers worldwide. The company’s growth and culture of innovation have set a new standard for the industry. It’s been a privilege to partner with Manuj Nikhanj, Jeff Hughes, and the full Enverus team. We are confident Enverus is exceptionally well-positioned to shape the future of global energy.”

“Supporting Enverus through this exciting period of innovation and growth has been a great journey,” said Eli Weiss, Managing Partner of Genstar Capital. “We’re proud of the team’s achievements and are confident they are well positioned for continued success.”

Enverus represents the latest in a number of recent transactions Blackstone has announced behind its high-conviction investment themes in electricity demand growth and the ongoing energy transition, such as TXNM EnergyPotomac Energy CenterSediverWestwood Professional ServicesTrystar, and others. Blackstone’s core private equity strategy, Blackstone Energy Transition Partners, and Blackstone’s private equity strategy for individual investors are each expected to invest in Enverus as part of this transaction.

Terms of the transaction were not disclosed. The transaction is expected to close by the end of the year, subject to customary conditions. Citi and Morgan Stanley & Co. LLC acted as financial advisors and Kirkland & Ellis LLP acted as legal advisor to Enverus and Hellman & Friedman. RBC Capital Markets served as financial advisor and Simpson Thacher & Bartlett LLP served as legal advisor to Blackstone.

About Blackstone

Blackstone is the world’s largest alternative asset manager. Blackstone seeks to deliver compelling returns for institutional and individual investors by strengthening the companies in which the firm invests. Blackstone’s $1.2 trillion in assets under management include global investment strategies focused on real estate, private equity, credit, infrastructure, life sciences, growth equity, secondaries and hedge funds. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, X (Twitter), and Instagram.

About Enverus

Enverus is the energy industry’s most trusted source for decision intelligence. With petabytes of proprietary data, deep domain expertise, and AI-native technology, Enverus empowers customers to invest smarter, operate more efficiently, and scale faster — across upstream, midstream, minerals, power, and renewables — all while navigating the most complex energy market in history. Learn more at www.enverus.com.

About Hellman & Friedman

Hellman & Friedman is a preeminent global private equity firm with a distinctive investment approach focused on a limited number of large-scale equity investments in high-quality growth businesses. H&F seeks to partner with world-class management teams where its deep sector expertise, long-term orientation, and collaborative partnership approach enable companies to flourish. H&F targets outstanding businesses in select sectors, including technology, financial services, healthcare, consumer services & retail, and information, content & business services. Since its founding in 1984, H&F has invested in over 100 companies and has over $115 billion in assets under management as of December 31, 2024. Learn more about H&F’s defining investment philosophy and approach to sustainable outcomes at www.hf.com.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high-quality companies for over 35 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $50 billion of assets under management and targets investments focused on targeted segments of the financial services, software, healthcare, and industrials industries.

Media Contacts

Blackstone
Matt Anderson
Matthew.Anderson@Blackstone.com
(518) 248-7310

Jennifer Heath
Jennifer.Heath@Blackstone.com
(347) 603-9256

Enverus
Jon Haubert
Jon.Haubert@enverus.com
(303) 396-5996

Hellman & Friedman
Dan Abernethy
Dan.Abernethy@fgsglobal.com
(646) 238-3902

Genstar Capital
FGS Global
GenstarCapital@fgsglobal.com

Categories: News

Tags: